PI BRAIN 22.2.2023
BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment
PI BRAIN 10.01.2023
BRAIN Group’s Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform.
PI BRAIN 27.9.2022
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand.